Intrinsiqq
HCA Healthcare Inc. logo

HCA Healthcare Inc. (HCA) Insider Trading

Last 12 months

Insiders sold $31.1M and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CEO Samuel N Hazen sold $21.5M on Feb 3 outside a plan. The last open-market buy by an executive or director was in Apr 2022.

Net open-market
−$31.1M
0 buys · 6 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 5
executives and directors
Last open-market buy
Apr 2022
Apr 29, 2022

Get an email when HCA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Feb 18No plan
    Michael R McAlevey
    EVP & Chief Legal & Admin Off. · sold 1,694 at $533.37
    $904k
    13% of stake
  • Feb 11No plan
    Christopher F. Wyatt
    SVP & Controller · sold 4,000 at $505.00
    $2.02M
    8.3% of stake
  • Feb 11No plan
    Jennifer Berres
    SVP & Chief Human Res. Officer · sold 8,020 at avg $514.58
    $4.13M
    40% of stake
  • Feb 3No plan
    Samuel N Hazen
    CEO · sold 42,877 at avg $501.04
    $21.5M
    3.1% of stake
  • Feb 3No plan
    Michael S. Cuffe
    EVP and Chief Clinical Officer · sold 1,500 at $498.09
    $747k
    5.5% of stake
  • Nov 5, 2025No plan
    Michael R McAlevey
    EVP & Chief Legal & Admin Off. · sold 3,892 at $473.79
    $1.84M
    41% of stake
  • Sep 8, 202510b5-1 plan
    Michael S. Cuffe
    EVP and Chief Clinical Officer · sold 3,836 at $418.84
    $1.61M
    11% of stake
  • May 13, 2025No plan
    Jon M Foster
    EVP and COO · sold 15,698 at $369.32
    $5.8M
    8.2% of stake
  • Mar 28, 2025No plan
    Bank OF America Corp
    Large holder · sold 3,178 at avg $25.11
    $80k
    100% of stake
  • Mar 28, 2025
    Bank OF America Corp
    Large holder · bought 3,436 at avg $25.67
    $88k
    New position
  • Feb 14, 2025No plan
    Jennifer Berres
    SVP & Chief Human Res. Officer · sold 9,533 at avg $322.59
    $3.08M
    38% of stake
  • Nov 14, 2024No plan
    Kathleen M Whalen
    SVP & Chief Ethics Officer · sold 1,474 at $357.99
    $528k
    13% of stake
  • Nov 14, 2024No plan
    Phillip G Billington
    SVP-Internal Audit Services · sold 3,897 at $350.00
    $1.36M
    6.9% of stake
  • Nov 14, 2024No plan
    Erol R Akdamar
    Group President · sold 2,900 at $353.00
    $1.02M
    2.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HCA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-General Medical & Surgical Hospitals, NEC

Spot a number that looks wrong? Check it in HCA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HCA

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.